Copyright Reports & Markets. All rights reserved.

Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Overview

      • 1.1 Product Overview and Scope of Dipeptide Peptidase 4 (DPP-4) Inhibitors
      • 1.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Segment by Type
        • 1.2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Sitagliptin
        • 1.2.3 Saxagliptin
        • 1.2.4 Linagliptin
        • 1.2.5 Alogliptin
        • 1.2.6 Vildagliptin
      • 1.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Segment by Application
        • 1.3.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Clinics
      • 1.4 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market by Region
        • 1.4.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size
        • 1.5.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2014-2025)
        • 1.5.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Production (2014-2025)

      2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Competition by Manufacturers

      • 2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Sites, Area Served, Product Types
      • 2.5 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Competitive Situation and Trends
        • 2.5.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Concentration Rate
        • 2.5.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Market Share by Regions

      • 3.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Market Share by Regions
      • 3.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Production
        • 3.4.1 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Growth Rate (2014-2019)
        • 3.4.2 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Production
        • 3.5.1 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Growth Rate (2014-2019)
        • 3.5.2 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Dipeptide Peptidase 4 (DPP-4) Inhibitors Production (2014-2019)
        • 3.6.1 China Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Growth Rate (2014-2019)
        • 3.6.2 China Dipeptide Peptidase 4 (DPP-4) Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Dipeptide Peptidase 4 (DPP-4) Inhibitors Production (2014-2019)
        • 3.7.1 Japan Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Growth Rate (2014-2019)
        • 3.7.2 Japan Dipeptide Peptidase 4 (DPP-4) Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption by Regions

      • 4.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption by Regions
      • 4.2 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption (2014-2019)
      • 4.3 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption (2014-2019)
      • 4.4 China Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption (2014-2019)
      • 4.5 Japan Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption (2014-2019)

      5 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Production, Revenue, Price Trend by Type

      • 5.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Market Share by Type (2014-2019)
      • 5.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Type (2014-2019)
      • 5.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Type (2014-2019)
      • 5.4 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Growth by Type (2014-2019)

      6 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Analysis by Applications

      • 6.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Market Share by Application (2014-2019)
      • 6.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Dipeptide Peptidase 4 (DPP-4) Inhibitors Business

      • 7.1 Merck
        • 7.1.1 Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Sites and Area Served
        • 7.1.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Introduction, Application and Specification
        • 7.1.3 Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Eli Lilly
        • 7.2.1 Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Sites and Area Served
        • 7.2.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Introduction, Application and Specification
        • 7.2.3 Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 AstraZenica
        • 7.3.1 AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Sites and Area Served
        • 7.3.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Introduction, Application and Specification
        • 7.3.3 AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Boehringer Ingelheim
        • 7.4.1 Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Sites and Area Served
        • 7.4.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Introduction, Application and Specification
        • 7.4.3 Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Takeda Pharmaceutical Company
        • 7.5.1 Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Sites and Area Served
        • 7.5.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Introduction, Application and Specification
        • 7.5.3 Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 BMS
        • 7.6.1 BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Sites and Area Served
        • 7.6.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Introduction, Application and Specification
        • 7.6.3 BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served

      8 Dipeptide Peptidase 4 (DPP-4) Inhibitors Manufacturing Cost Analysis

      • 8.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Dipeptide Peptidase 4 (DPP-4) Inhibitors
      • 8.4 Dipeptide Peptidase 4 (DPP-4) Inhibitors Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Distributors List
      • 9.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Forecast

      • 11.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Production, Revenue Forecast
        • 11.1.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price and Trend Forecast (2019-2025)
      • 11.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Dipeptide Peptidase 4 (DPP-4) Inhibitors Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Dipeptide Peptidase 4 (DPP-4) Inhibitors Production, Revenue Forecast (2019-2025)
      • 11.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Forecast (2019-2025)
        • 11.3.2 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Forecast (2019-2025)
        • 11.3.3 China Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Forecast (2019-2025)
        • 11.3.4 Japan Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Forecast (2019-2025)
      • 11.4 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Dipeptide Peptidase 4 (DPP-4) Inhibitors are a class of oral diabetes drugs that work by blocking the action of DPP-4, an enzyme which destroys a group of gastrointestinal hormones called incretins. Incretins help stimulate the production of insulin when it is needed (e.g. after eating) and reduce the production of glucagon by the liver when it is not needed (e.g. during digestion). They also slow down digestion and decrease appetite. So by protecting incretins from damage, DPP-4 inhibitors help regulate blood glucose levels.
        Januvia (Sitagliptin), Galvus (Vildagliptin), Onglyza (Saxagliptin), Tradjenta (Linagliptin) are the major DPP-4 drugs in the market.

        The global Dipeptide Peptidase 4 (DPP-4) Inhibitors market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Dipeptide Peptidase 4 (DPP-4) Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Dipeptide Peptidase 4 (DPP-4) Inhibitors market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Merck
        Eli Lilly
        AstraZenica
        Boehringer Ingelheim
        Takeda Pharmaceutical Company
        BMS
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Sitagliptin
        Saxagliptin
        Linagliptin
        Alogliptin
        Vildagliptin

        Segment by Application
        Hospitals
        Clinics

        Buy now